We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

82 hedge funds and large institutions have $243M invested in Nautilus Biotechnolgy in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

537% more call options, than puts

Call options by funds: $586K | Put options by funds: $92K

31% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 16

1% more funds holding

Funds holding: 81 → 82 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

4% more capital invested

Capital invested by funds: $235M → $243M (+$8.62M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

2.95% less ownership

Funds ownership: 47.97% → 45.03% (-2.9%)

Holders
82
Holders Change
+1
Holders Change %
+1.23%
% of All Funds
1.29%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
21
Reduced
16
Closed
16
Calls
$586K
Puts
$92K
Net Calls
+$494K
Net Calls Change
-$1.22M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.38M
2
TM
Tikvah Management
North Carolina
+$1.06M
3
Millennium Management
Millennium Management
New York
+$1.04M
4
ECM
ExodusPoint Capital Management
New York
+$566K
5
HF
HRT Financial
New York
+$456K

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$12.6M
2
O
OrbiMed
New York
-$7.53M
3
Franklin Resources
Franklin Resources
California
-$3.97M
4
AAA
Affinity Asset Advisors
New York
-$2.01M
5
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
26
Pura Vida Investments
New York
$1.06M +$414K +100,900 +70%
HC
27
Hillman Company
Pennsylvania
$868K – – –
SGM
28
Skye Global Management
Florida
$853K +$355K +86,500 +79%
State Street
29
State Street
Massachusetts
$807K +$35.9K +8,755 +5%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$779K +$87.6K +21,343 +13%
Northern Trust
31
Northern Trust
Illinois
$609K -$16.5K -4,023 -3%
ECM
32
ExodusPoint Capital Management
New York
$598K +$566K +137,826 New
Ensign Peak Advisors
33
Ensign Peak Advisors
Utah
$585K – – –
HF
34
HRT Financial
New York
$482K +$456K +111,158 New
Goldman Sachs
35
Goldman Sachs
New York
$406K +$147K +35,888 +62%
ST
36
Sentinel Trust
Texas
$369K +$349K +85,000 New
Bank of America
37
Bank of America
North Carolina
$333K +$298K +72,578 +1,748%
SCP
38
Sender Company & Partners
New York
$321K -$285K -69,375 -48%
SM
39
Sciencast Management
New Jersey
$283K +$261K +63,529 New
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$270K +$254K +62,000 New
Citadel Advisors
41
Citadel Advisors
Florida
$254K +$176K +42,827 +274%
Morgan Stanley
42
Morgan Stanley
New York
$222K +$35.6K +8,664 +20%
LOAMU
43
Lombard Odier Asset Management (USA)
New York
$217K – – –
Squarepoint
44
Squarepoint
New York
$185K +$175K +42,626 New
Barclays
45
Barclays
United Kingdom
$180K +$170K +41,516 New
S
46
SignatureFD
Georgia
$162K – – –
MFS
47
Mirabella Financial Services
United Kingdom
$158K +$89.9K +21,903 +152%
FIA
48
FNY Investment Advisers
New York
$137K +$78.2K +19,040 +151%
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
$127K +$120K +29,212 New
Jane Street
50
Jane Street
New York
$125K +$67.5K +16,456 +132%
1
2
3 4

NAUT Hedge Fund Activity: Q1 2022 in Review

82 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q1 2022, worth a combined $243M — up 3.7% from $235M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new NAUT positions and 16 closed out — a net gain of 1 holder — while 21 added to existing stakes and 16 trimmed.

The largest buyer was Vanguard Group, adding an estimated $4.38M. The largest seller was RA Capital Management, exiting entirely with an estimated $12.6M sold.

  • 82 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q1 2022, up from 81 in Q4 2021.
  • Funds reported $243M of Nautilus Biotechnolgy stock for Q1 2022, up 3.7% quarter-over-quarter.
  • 17 funds opened new Nautilus Biotechnolgy positions in Q1 2022 and 16 closed out, a net change of +1 holder.
  • The largest Nautilus Biotechnolgy buyer in Q1 2022 was Vanguard Group, an estimated $4.38M added.
  • The largest Nautilus Biotechnolgy seller in Q1 2022 was RA Capital Management, an estimated $12.6M sold.

Based on aggregated 13F filings for Q1 2022.